Researchers In Philippines Develop Machine To Quickly Detect Drug-Resistant TB

In this post in the Global Post’s “Global Pulse” blog, journalist John Donnelly reports on how a machine developed by researchers at the TB Laboratory at the Lung Center of the Philippines “that can detect multi-drug resistant [tuberculosis (MDR-TB)] in record time may revolutionize TB treatment.” According to the blog, the GeneXpert, dubbed by researchers as the “espresso maker,” grew out of collaboration among partners put together by the Foundation for Innovative New Diagnostics in Geneva and “can detect [MDR-TB] in two hours instead of the old way of growing cultures that took two months.”

“With financial help from the Global Fund to Fight AIDS, TB, and Malaria, the Philippines has purchased 20 GeneXpert machines and has begun to distribute them to provinces around the country,” the blog states. Donnelly and photographer Riccardo Venturi visited the lab as the first stop in a three-country tour, during which the pair, acting independently, “met with scientists, doctors and patients to explore the scope of the struggle to fight MDR-TB,” Donnelly writes (11/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.